Bypass NFkappaB-mediated survival pathways by TRAIL and Smac

Related Experiment Video

Updated: Jul 13, 2026

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
04:20

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Published on: February 9, 2024

Xiaoyang Ren1, Zhengming Xu, Jeffery N Myers

  • 1Huffington Center on Aging, Baylor College of Medicine, Houston, Texas, USA.

Cancer Biology & Therapy
|July 6, 2007
PubMed

Insights

This study shows that combining TRAIL and a Smac analog can overcome NF-kappaB-mediated resistance to cancer cell death. This approach offers a potentially low-toxicity strategy to improve cancer therapy by bypassing NF-kappaB activation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Nuclear Factor kappa B (NF-kappaB) activation is common in malignancies, promoting cancer cell survival and resistance to therapy.
  • Directly inhibiting NF-kappaB can cause severe side effects due to its essential cellular functions.
  • Novel strategies are needed to overcome NF-kappaB-mediated cell survival with low cytotoxicity.

Purpose of the Study:

  • To investigate a novel therapeutic strategy using TRAIL/Apo2L and a Smac analog to overcome NF-kappaB activation in cancer.
  • To evaluate the efficacy of this combined approach in head and neck squamous cell carcinoma (HNSCC) models.
  • To assess the potential for low toxicity by bypassing direct NF-kappaB inhibition.

Main Methods:

  • Utilized TRAIL/Apo2L (TNF-related apoptosis-inducing ligand) and a Smac (Second mitochondria-derived activator of caspases) analog.
  • Tested the sensitivity of HNSCC cell lines to TRAIL-induced apoptosis.
  • Investigated the role of NF-kappaB in TRAIL resistance and the effect of the combined treatment.

Main Results:

  • HNSCC cell lines exhibited resistance to TRAIL-induced apoptosis due to activated NF-kappaB pathways.
  • Inhibition of NF-kappaB sensitized HNSCC cells to TRAIL.
  • Co-treatment with TRAIL and the Smac analog induced cancer cell death by overcoming and bypassing NF-kappaB activation.
  • This combination therapy demonstrated tumor selectivity and potentially low toxicity.

Conclusions:

  • TRAIL and Smac analog co-treatment is a promising strategy to overcome NF-kappaB-mediated resistance in cancer.
  • This approach bypasses NF-kappaB activation, offering a potentially safer alternative to direct inhibition.
  • The tumor-selective nature of TRAIL suggests therapeutic benefits with reduced systemic toxicity.

More Related Videos

Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling08:51

Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling

Published on: June 25, 2015

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...